SBIR/STTR Research Award
SBIR Phase I: At home, single dose mRNA vaccine patch (COVID-19)
Award amount
$256,000Program and phase
SBIR · Phase IAward year
2020Award details
- Awarding agency
- National Science Foundation
- Branch
- Not reported
- Recipient company
- VAXESS TECHNOLOGIES INC
- Proposal award date
- 2020-09-01
- Contract end date
- 2021-02-28
- UEI
- HNLJN8YZPVJ3
- Solicitation number
- Not reported
- Topic code
- PT
Research abstract
The broader impact / commercial potential of this Small Business Innovation Research (SBIR) Phase I project will be to provide a new vaccine for the COVID-19 pandemic. To date millions have been infected, with hundreds of thousands of deaths. Leading vac
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Development of a Needle Free Microarray Patch for Delivery of a GLP-1 Receptor Agonist
- Microarray Patch for Broadly Protective Seasonal Influenza Vaccination
- Improved Influenza Vaccine Efficacy Through Infection Mimicry
- Improved Influenza Vaccine Efficacy Through Infection Mimicry
- Silk-based biospecimen stabilization for exposure assessment diagnostics
Research funding history
11 SBIR/STTR records share this UEI (2015–2024). Reported award amounts total $9,792,329. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, National Science Foundation